PCNSL

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

InnoCare
InnoCareChina - Beijing
1 program
1
ICP-022Phase 21 trial
Active Trials
NCT04438044Unknown61Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
InnoCareICP-022

Clinical Trials (1)

Total enrollment: 61 patients across 1 trials

A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL

Start: Jun 2019Est. completion: Dec 202361 patients
Phase 2Unknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space